# PORTEC-3 (NCT00411138)

> Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00411138
- Phase: PHASE3
- Status: UNKNOWN
- Sponsor: Leiden University
- Conditions: Endometrial Cancer
- Interventions: Radiation Therapy; cisplatin; carboplatin; Paclitaxel
- Enrollment: 670
- Primary outcome: Overall survival
- Primary outcome: Failure-free survival

## Commentary we found

- X threads: 23
- YouTube: 21
- Podcasts: 15

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=portec-3-nct00411138

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00411138", "email": "<work email>"}; the inbox owner confirms by the emailed link.